PrimeGene (Beijing)'s last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·Watch PrimeGene (Beijing): the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
PrimeGene (Beijing) funding history
No funding rounds for PrimeGene (Beijing) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
PrimeGene (Beijing) valuation
PrimeGene (Beijing)'s last reported valuation was $248 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
How PrimeGene (Beijing)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For PrimeGene (Beijing), the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about PrimeGene (Beijing)
- What is PrimeGene (Beijing) worth?
- PrimeGene (Beijing) is valued at $248.0M as of Oct 2026. PrimeGene (Beijing)'s last reported valuation, Jan 2025. Nothing priced has surfaced since.
- How much has PrimeGene (Beijing) raised?
- PrimeGene (Beijing) has raised $85.6M in total funding across its recorded rounds.